In the race to develop a treatment for COVID-19, Gilead Sciences may have found a winner with remdesivir. In a study by Vanderbilt University Medical Center, the University of North Carolina at Chapel Hill, and Gilead, researchers found that the experimental drug inhibited the coronavirus in human lung cell cultures …
Read More »